These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2170647)

  • 21. Leukotriene B4 (LTB4) receptor antagonists: a series of (hydroxyphenyl)pyrazoles.
    Harper RW; Jackson WT; Froelich LL; Boyd RJ; Aldridge TE; Herron DK
    J Med Chem; 1994 Jul; 37(15):2411-20. PubMed ID: 8057289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trisubstituted benzene leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
    Konno M; Nakae T; Sakuyama S; Odagaki Y; Nakai H; Hamanaka N
    Bioorg Med Chem; 1997 Aug; 5(8):1649-74. PubMed ID: 9313868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
    Huang FC; Galemmo RA; Johnson WH; Poli GB; Morrissette MM; Mencel JJ; Warus JD; Campbell HF; Nuss GW; Carnathan GW
    J Med Chem; 1990 Apr; 33(4):1194-200. PubMed ID: 2157010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotriene B4 binding sites in guinea-pig alveolar macrophages.
    de Brum-Fernandes AJ; Guillemette G; Sirois P
    Prostaglandins; 1990 Nov; 40(5):515-27. PubMed ID: 2175041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desensitization of the leukotriene B4 receptor by partial agonists.
    Kiel D; Zipkin RE; Feinmark SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():403-6. PubMed ID: 1847776
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the receptor system for leukotriene B4 on human neutrophils.
    Goldman DW
    Ann N Y Acad Sci; 1988; 524():187-95. PubMed ID: 2837954
    [No Abstract]   [Full Text] [Related]  

  • 28. Protein kinase C regulates leukotriene B4 receptors in human neutrophils.
    O'Flaherty JT; Redman JF; Jacobson DP
    FEBS Lett; 1986 Oct; 206(2):279-82. PubMed ID: 3019772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene B4 receptors on rat and human neutrophil membranes.
    Ford-Hutchinson AW; Charleson S; Evans JF
    Methods Enzymol; 1988; 163():340-3. PubMed ID: 2853282
    [No Abstract]   [Full Text] [Related]  

  • 30. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels.
    Maloff BL; Fox D; Bruin E; Di Meo TM
    Eur J Pharmacol; 1988 Dec; 158(1-2):85-9. PubMed ID: 2851461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression of leukotriene B4 and leukotriene D4 receptors on human monocytic leukemia U-937 cells.
    Sarau HM; Mong S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():180-6. PubMed ID: 2546381
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
    Ng CF; Sun FF; Taylor BM; Wolin MS; Wong PY
    J Immunol; 1991 Nov; 147(9):3096-103. PubMed ID: 1655904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4.
    Goldman DW; Gifford LA; Marotti T; Koo CH; Goetzl EJ
    Fed Proc; 1987 Jan; 46(1):200-3. PubMed ID: 3026857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monocytes respond to leukotriene B4 with a transient increase in cytosolic calcium.
    Rediske J; Morrissey MM; Jarvis M
    Cell Immunol; 1993 Apr; 147(2):438-45. PubMed ID: 8384085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
    Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appearance of specific leukotriene B4 binding sites in myeloid differentiated HL-60 cells.
    Benjamin CW; Rupple PL; Gorman RR
    J Biol Chem; 1985 Nov; 260(26):14208-13. PubMed ID: 2997200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the soluble leukotriene B4 receptor from sheep lung membranes.
    Votta B; Keefer J; Mong S
    Biochem J; 1990 Aug; 270(1):213-8. PubMed ID: 2168701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
    Mong S; Chi-Rosso G; Miller J; Hoffman K; Razgaitis KA; Bender P; Crooke ST
    Mol Pharmacol; 1986 Sep; 30(3):235-42. PubMed ID: 3018480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid differentiated HL-60 cells display specific leukotriene B4 binding sites.
    Gorman RR; Ruppel PL; Benjamin CW
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():165-77. PubMed ID: 3028094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
    Youssefyeh RD; Magnien E; Lee TD; Chan WK; Lin CJ; Galemmo RA; Johnson WH; Tan J; Campbell HF; Huang FC
    J Med Chem; 1990 Apr; 33(4):1186-94. PubMed ID: 2157009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.